Clarius Group LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.61M | Sell |
7,988
-819
| -9% | -$260K | 0.15% | 60 |
|
|
2025
Q3 | $2.49M | Sell |
8,807
-1,405
| -14% | -$407K | 0.15% | 62 |
|
|
2025
Q2 | $2.85M | Sell |
10,212
-65
| -0.6% | -$18.4K | 0.17% | 61 |
|
|
2025
Q1 | $3.2M | Buy |
10,277
+1,970
| +24% | +$582K | 0.2% | 57 |
|
|
2024
Q4 | $2.17M | Buy |
8,307
+27
| +0.3% | +$8.01K | 0.15% | 66 |
|
|
2024
Q3 | $2.66M | Sell |
8,280
-131
| -2% | -$42.9K | 0.19% | 55 |
|
|
2024
Q2 | $2.63M | Sell |
8,411
-229
| -3% | -$67.3K | 0.19% | 55 |
|
|
2024
Q1 | $2.46M | Sell |
8,640
-1,178
| -12% | -$345K | 0.17% | 58 |
|
|
2023
Q4 | $2.83M | Buy |
9,818
+2,913
| +42% | +$794K | 0.23% | 56 |
|
|
2023
Q3 | $1.86M | Sell |
6,905
-916
| -12% | -$229K | 0.18% | 68 |
|
|
2023
Q2 | $1.74M | Buy |
7,821
+303
| +4% | +$70.3K | 0.13% | 83 |
|
|
2023
Q1 | $1.82M | Sell |
7,518
-209
| -3% | -$51.3K | 0.15% | 74 |
|
|
2022
Q4 | $2.03M | Buy |
7,727
+143
| +2% | +$38.3K | 0.18% | 73 |
|
|
2022
Q3 | $1.71M | Buy |
7,584
+187
| +3% | +$45.3K | 0.17% | 75 |
|
|
2022
Q2 | $1.8M | Buy |
7,397
+328
| +5% | +$80.4K | 0.18% | 72 |
|
|
2022
Q1 | $1.59M | Hold |
7,069
| – | – | 0.13% | 95 |
|
|
2021
Q4 | $1.59M | Buy |
7,069
+131
| +2% | +$27.6K | 0.13% | 95 |
|
|
2021
Q3 | $1.48M | Sell |
6,938
-356
| -5% | -$81.9K | 0.13% | 91 |
|
|
2021
Q2 | $1.78M | Buy |
7,294
+4
| +0.1% | +$984 | 0.16% | 77 |
|
|
2021
Q1 | $1.81M | Buy |
7,290
+454
| +7% | +$108K | 0.18% | 64 |
|
|
2020
Q4 | $1.57M | Buy |
6,836
+599
| +10% | +$138K | 0.17% | 69 |
|
|
2020
Q3 | $1.58M | Buy |
6,237
+36
| +0.6% | +$8.92K | 0.2% | 57 |
|
|
2020
Q2 | $1.46M | Buy |
6,201
+748
| +14% | +$171K | 0.21% | 59 |
|
|
2020
Q1 | $1.1M | Sell |
5,453
-162
| -3% | -$35.4K | 0.21% | 59 |
|
|
2019
Q4 | $1.36M | Buy |
5,615
+268
| +5% | +$59.1K | 0.21% | 63 |
|
|
2019
Q3 | $1.03M | Buy |
5,347
+1,095
| +26% | +$210K | 0.19% | 69 |
|
|
2019
Q2 | $784K | Buy |
4,252
+322
| +8% | +$57.7K | 0.16% | 76 |
|
|
2019
Q1 | $747K | Buy |
3,930
+979
| +33% | +$187K | 0.18% | 73 |
|
|
2018
Q4 | $574K | Buy |
2,951
+480
| +19% | +$93.6K | 0.21% | 57 |
|
|
2018
Q3 | $512K | Buy |
2,471
+1,213
| +96% | +$239K | 0.18% | 59 |
|
|
2018
Q2 | $232K | Hold |
1,258
| – | – | 0.1% | 76 |
|
|
2018
Q1 | $214K | Hold |
1,258
| – | – | 0.1% | 57 |
|
|
2017
Q4 | $219K | Hold |
1,258
| – | – | 0.1% | 58 |
|
|
2017
Q3 | $235K | Sell |
1,258
-1,103
| -47% | -$195K | 0.1% | 59 |
|
|
2017
Q2 | $407K | Buy |
2,361
+87
| +4% | +$14.2K | 0.17% | 59 |
|
|
2017
Q1 | $373K | Hold |
2,274
| – | – | 0.15% | 61 |
|
|
2016
Q4 | $333K | Sell |
2,274
-305
| -12% | -$45.9K | 0.14% | 64 |
|
|
2016
Q3 | $431K | Buy |
2,579
+1
| +0% | +$169 | 0.2% | 55 |
|
|
2016
Q2 | $392K | Sell |
2,578
-133
| -5% | -$20.7K | 0.21% | 55 |
|
|
2016
Q1 | $405K | Buy |
2,711
+133
| +5% | +$19.8K | 0.22% | 53 |
|
|
2015
Q4 | $418K | Buy |
+2,578
| New | +$405K | 0.24% | 44 |
|
Other funds holding AMGN
Clarius Group LLC's AMGN Position: Q4 2025 in Review
Clarius Group LLC reduced its Amgen (AMGN) stake by 9.3% in Q4 2025, selling an estimated $260K and leaving 7,988 shares worth $2.61M. The position accounts for 0.15% of the portfolio, ranked #60.
Clarius Group LLC first reported a position in AMGN in Q4 2015 and has held it in 41 quarters since. The position peaked at $3.2M in Q1 2025. 3,085 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Clarius Group LLC held 7,988 shares of Amgen worth $2.61M as of Q4 2025.
- Clarius Group LLC sold 819 Amgen shares in Q4 2025, an estimated $260K.
- Amgen made up 0.15% of Clarius Group LLC's portfolio in Q4 2025, its #60 holding.
- Clarius Group LLC first reported a position in Amgen in Q4 2015 and has held it in 41 quarters since.
- Clarius Group LLC's Amgen position peaked at $3.2M in Q1 2025.
- 3,085 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.